|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
70,540,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,776,453 |
Avg
Vol: |
2,215,743 |
52
Week Range: |
$49.96 - $49.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brooke Paul A |
Director |
|
2013-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
119,000 |
|
- |
|
Brooke Paul A |
Director |
|
2013-02-20 |
4 |
OE |
$1.77 |
$17,700 |
D/D |
10,000 |
114,500 |
|
- |
|
Brooke Paul A |
Director |
|
2013-02-06 |
4/A |
OE |
$1.77 |
$17,700 |
D/D |
10,000 |
114,500 |
|
- |
|
Mchugh Julie |
Director |
|
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,083 |
2,083 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-27 |
4 |
OE |
$1.84 |
$18,400 |
D/D |
10,000 |
30,167 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-24 |
4/A |
AS |
$22.53 |
$394,301 |
D/D |
(17,500) |
20,167 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-24 |
4 |
AS |
$22.53 |
$394,301 |
D/D |
(17,500) |
37,667 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-24 |
4 |
OE |
$1.84 |
$32,200 |
D/D |
17,500 |
55,167 |
|
- |
|
Brooke Paul A |
Director |
|
2012-12-13 |
4 |
S |
$23.87 |
$1,431,954 |
D/D |
(60,000) |
104,500 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-10 |
4 |
S |
$24.07 |
$1,805,016 |
D/D |
(74,999) |
37,667 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2012-12-10 |
4 |
OE |
$5.91 |
$651,490 |
D/D |
74,999 |
52,666 |
|
- |
|
Claypool William D Md |
Director |
|
2012-12-03 |
4 |
S |
$24.80 |
$248,000 |
D/D |
(10,000) |
44,500 |
|
- |
|
Wolf John Peter Iii |
VP, General Counsel |
|
2012-12-03 |
4 |
S |
$24.85 |
$447,257 |
D/D |
(18,000) |
0 |
|
- |
|
Wolf John Peter Iii |
VP, General Counsel |
|
2012-12-03 |
4 |
OE |
$3.14 |
$56,520 |
D/D |
18,000 |
18,000 |
|
- |
|
Dougherty Michael R |
Director |
|
2012-12-03 |
4 |
B |
$25.07 |
$62,675 |
D/D |
2,500 |
7,000 |
2.39 |
- |
|
Glaser Robert |
Director |
|
2012-11-30 |
4 |
S |
$24.78 |
$743,385 |
D/D |
(30,000) |
41,360 |
|
- |
|
Glaser Robert |
Director |
|
2012-11-30 |
4 |
OE |
$3.00 |
$261,500 |
D/D |
30,000 |
51,360 |
|
- |
|
Claypool William D Md |
Director |
|
2012-11-28 |
4 |
S |
$24.22 |
$423,880 |
D/D |
(17,500) |
54,500 |
|
- |
|
Claypool William D Md |
Director |
|
2012-11-28 |
4 |
OE |
$5.68 |
$175,600 |
D/D |
17,500 |
69,500 |
|
- |
|
Milano Vincent |
President and CEO |
|
2012-11-28 |
4 |
OE |
$3.55 |
$63,900 |
D/D |
18,000 |
112,416 |
|
- |
|
Claypool William D Md |
Director |
|
2012-11-13 |
4 |
S |
$24.84 |
$561,011 |
D/D |
(22,500) |
54,500 |
|
- |
|
Claypool William D Md |
Director |
|
2012-11-13 |
4 |
OE |
$5.68 |
$162,500 |
D/D |
22,500 |
67,000 |
|
- |
|
Milano Vincent |
President and CEO |
|
2012-11-08 |
4 |
S |
$24.54 |
$2,047,328 |
D/D |
(83,418) |
94,416 |
|
- |
|
Milano Vincent |
President and CEO |
|
2012-11-08 |
4 |
OE |
$3.14 |
$378,273 |
D/D |
83,418 |
135,834 |
|
- |
|
Claypool William D Md |
Director |
|
2012-11-02 |
4 |
S |
$25.37 |
$253,703 |
D/D |
(10,000) |
54,500 |
|
- |
|
412 Records found
|
|
Page 4 of 17 |
|
|